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Objective. To study the antimicrobial susceptibility of six vaginal probiotic lactobacilli. Methods. The disc diﬀusion method in
M¨ ueller Hinton, LAPTg and MRS agars by the NCCLS (National Committee for Clinical Laboratory Standards) procedure was
performed. Due to the absence of a Lactobacillus reference strains, the results were compared to those of Staphylococcus aureus
ATCC29213. Minimal Inhibitory Concentration (MIC) with 21 diﬀerent antibiotics in LAPTg agar and broth was also deter-
mined. Results. LAPTg and MRS agars are suitable media to study antimicrobial susceptibility of lactobacilli. However, the NCCLS
procedureneeds tobestandardizedforthisgenus. TheMICshave shownthatallLactobacillusstrainsgrewat concentrations above
10 µg/mL of chloramphenicol, aztreonam, norﬂoxacin, ciproﬂoxacin, ceftazidime, ceftriaxone, streptomycin and kanamycin. Four
lactobacilli were sensitive to 1 µg/mL vancomycin and all of them were resistant to 1000 µg/mL of metronidazole. Sensitivity to
other antibiotics depended on each particular strain. Conclusions. The NCCLS method needs to be standardized in an appropri-
ate medium to determine the antimicrobial susceptibility of Lactobacillus. Vaginal probiotic lactobacilli do not display uniform
susceptibility to antibiotics. Resistance to high concentrations of metronidazole suggests that lactobacilli could be simultaneously
used with a bacterial vaginosis treatment to restore the vaginal normal ﬂora.
Copyright © 2006 Virginia Oca˜ na et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Bacteria of the genus Lactobacillus have been proposed as
probiotic microorganisms to restore the ecological equilib-
rium of the intestinal, respiratory, and urogenital tracts [1].
This type of bacterial replacement therapy has been widely
used as fermented milks to prevent diarrhea in humans and
animals [2, 3]. They have also been increasingly considered
for their use in women to prevent genital and urinary tract
infections [4–8].
It has been found that administration of antimicrobial
substancesaltersthemicrobialbalanceofthevaginaandsup-
p r e s s e sc e r t a i nb a c t e r i a lg r o u p s[ 4]. The eﬀect of these sub-
stances on autochthonous Lactobacillus is of interest in un-
derstanding the development of genital and urinary tract in-
fections related with the lack of these bacteria [9].
The present study was conducted to determine the an-
timicrobial susceptibility of six candidate probiotic Lacto-
bacillus strains. These lactobacilli have been previously se-
lected for probiotic properties as surface hydrophobicity
[10], self-and coaggregation [11], adhesion to vaginal ep-
ithelialcells[12],andproductionofantimicrobialsubstances
[13–15]. The main aims of knowing the behavior of exoge-
nously applied Lactobacillus under the eﬀect of antimicrobial
substances are to have an approach of the response of lacto-
bacilliadministered topatientssubjectedtosomekind ofan-
tibiotic therapy and to consider the concomitant use of lac-
tobacilli and an antibiotic to restore the disrupted ecological
environment.
Having in mind that a method to study antimicrobial
susceptibility of genus Lactobacillus has not been standard-
ized yet, diﬀerent techniques were assayed. The results ob-
tained by using the disc diﬀusion method with culture media
diﬀerent from M¨ uller Hinton agar proposed by the NCCLS
(NationalCommitteeforClinicalLaboratoryStandards)and
the determination of the minimal inhibitory concentrations
in an enriched medium are described in this paper.
MATERIALS AND METHODS
Microorganismsandgrowthconditions
The microorganisms used in this study were Lactobacillus
acidophilus CRL1251 (Centro de Referencia para Lactobaci-
los Culture Collection), Lactobacillus paracasei ssp paracasei2 Infectious Diseases in Obstetrics and Gynecology
CRL1289, Lacidophilus CRL1266 (H202-generating strains),
Lg a s s e r iCRL1259 (organic acid producer), Lj o h n s o n i i
CRL1294 (aggregating), and L salivarius CRL1328 (bacteri-
ocin producer). They have been isolated from the human
vagina of women from Tucum´ an, Argentina, and identiﬁed
by biochemical proﬁles, sugar fermentation patterns, and
API 50 system (BioM´ erieux Vitec, Inc, France) [10]. NC-
CLS type strain, Staphylococcus aureus ATCC29213 from the
American Type Culture Collection, was employed as refer-
ence strain.
All the microorganisms were stored in milk-yeast extract
at −70◦C. Prior to the assays, they were subcultured twice in
LAPTg broth [16], and a third time in the media where the
susceptibility to antibiotics assay was going to be performed:
MRS [17], LAPTg, or M¨ uller Hinton broth.
Antimicrobialagents
Inhibitors of the cell wall synthesis (oxacillin, aminopenicil-
lins, ceftazidime, ceftriaxone, cefotaxime, imipenem, aztre-
onam, and vancomycin), protein synthesis (kanamycin, gen-
tamicin, streptomycin, tetracyclines, chloramphenicol, clar-
ithromycin, erythromycin, and nitrofurantoin), and nucleic
acid synthesis (trimethoprim-sulfamethoxazole, rifampin;
norﬂoxacin, ciproﬂoxacin, nalidixic acid, pipemidic acid,
and metronidazole) were employed for inhibition tests.
They were used as commercial discs (Britania, Argentina)
or prepared from drugs provided by diﬀerent companies
(Sigma, USA; Merck, Germany; Britania, Argentina; ICN,
Argentina).
Discdiffusionmethod
Antimicrobial susceptibility was studied by employing the
method described by Bauer et al [18] for clinical isolates,
modiﬁed by using three diﬀerent base agar media: M¨ uller
Hinton, LAPTg, and MRS agars. Frozen microorganisms
were subcultured twice in LAPTg broth and a third time
i nM R S ,L A P T g ,o rM ¨ uller Hinton broth for 14 hours at
37◦C. Suspensions were adjusted to tube 5 in McFarland
scale (108CFU/mL) and the microorganisms were (a) dis-
seminated on the surface of MRS, LAPTg, or M¨ uller Hin-
ton agar plates with embedded swabs and (b) included into
the agar. To include the lactobacilli into the agar, 100µLo f
the microbial suspension were mixed with 12mL of melted
agar (melted and cooled down to 45◦C )a n dt h e np o u r e do n
plates. Antibiotic discs were placed on the surface of the agar
(six discs in each plate) and the plates were incubated for
24 to 48 hours at 37◦C under microaerophilic conditions.
After the incubation, the diameter of the halos was mea-
sured.
Minimalinhibitoryconcentrations
The MICs were determined in LAPTg broth and agar. Solu-
tions of each antibiotic at concentrations of 10 to 50mg/mL
were prepared. They were serially diluted in LAPTg broth
and added to LAPTg broth or 45◦Cm e l t e da g a rt oo b t a i n
Figure 1: Semiquantitative disc assay developed in LAPTg agar for
Lactobacillus acidophilus CRL1251 inoculated on the surface.
ﬁnal concentrationsof 1to 1000µg/mL.Fifty µLo fe xpo ne n-
tial growth phase microorganisms at concentration of 107
to 108 CFU/mL were inoculated in LAPTg with antibiotics.
Cultures were incubated up to 48 hours at 37◦C and the in-
hibition of growth was spectrophotometrically determined
at 540mn (Gilford Spectrophotometer, USA) for assays per-
formed in LAPTg broth and by macroscopic observation for
agar tests.
Statisticalevaluation
The disc diﬀusion method was performed by duplicate and
the diameters obtained for each strain are represented in the
tables. MIC test was performed by triplicate. Complete inhi-
bition of growth in all three tubes or plaques with the same
antibiotic concentration was considered as the MIC.
RESULTS
Discdiffusionmethod
Growth of lactobacilli in M¨ uller Hinton broth was poor and
when any type of growth was detected on the agar, it was ir-
regular and the halos were undeﬁned. In LAPTg agar the in-
hibitionhalosweresharplydeﬁned(Figure 1)andthediame-
ters could be easily measured when the microorganisms were
inoculatedeitheronthesurfaceorintotheagar.Ontheother
side, the diameters of the halos for lactobacilli inoculated
on the surface or into the agar were hardly diﬀerent (data
not shown). Lg a s s e r iCRL1259 and Lj o h n s o n i iCRL1294 did
not grow when they were included into the MRS agar plates
while none of the six tested lactobacilli were able to grow in
this media when they were spread on the surface. For those
strains that were able to grow in MRS and LAPTg agars, the
diameters of the inhibition halos were wider in MRS than in
LAPTg agar for most of the antibiotics tested, as shown in
Table 1.
In order to know whether LAPTg or MRS agar was ap-
propriate to be used as a base medium in a standardized
method for Lactobacillus, the eﬀect of antibiotics on an NC-
CLS selected type strain inoculated in this medium was eval-
uated. If the halos for the type strain in LAPTg or MRS agarVirginia Oca˜ na et al 3
Table 1: Diameters of the halos obtained for lactobacilli included into LAPTg and MRS agars and tested with antibiotics employed in am-
bulatory UTI treatment. TMS: trimethoprim-sulfamethoxazole (25µg ) ,C E C :c e f a c l o r( 3 0µg), NOR: norﬂoxacin (10µg), NAL: nalidixic
acid (30µg), PMD: pipemidic acid (20µg), AMN: ampicillin (10µg), CEF: cephalosporin (30µg), NIT: nitrofurantoin (300µg), AMS:
aminopenicillin-sulbactam (20µg). Note: commercial discs do not specify the type of cephalosporin employed.
Strain Antibiotic
Media SXT CEC NOR NAL PMD AMP CEP NIT AMS
CRL 1251 LAPTg 23/25 29/31 19/21 17/19 21/23 37/39 39/41 30/30 > 39
MRS > 40 > 40 31/33 25/27 30/30 > 40 > 40 > 40 > 40
CRL 1266 LAPTg 20/22 30/34 16/22 18/20 20/24 30/34 30/32 20–26 34–36
MRS > 28 > 30 21/23 19/21 17/19 40/40 > 30 > 30 > 28
CRL 1289 LAPTg 30/30 36/36 24/30 20/30 30/34 36/36 30/36 30/30 40/40
MRS > 34 > 34 33/35 29/31 29/31 33/35 27/29 21/23 40/40
CRL 1328 LAPTg 26/28 34/34 16/18 11/12 18/22 30/34 36/38 24/26 34734
MRS 29/31 23/25 27/29 17/19 27/29 37/39 39/41 27/29 35/37
Table 2: Inhibition halos for Staphylococcus aureus ATCC29213 in LAPT and MRS agars compared to results published for NCCLS reference
media using antibiotics for UTI treatment. SXT: trimethoprim-sulfamethoxazole, CEC: cefaclor, NOR: norﬂoxacin, NAL: nalidixic acid,
PMD: pipemidic acid, AMP: ampicillin, CEP: cephalosporin, NIT: nitrofurantoin, SAM: aminopenicillin-sulbactam. Means of the diameters
obtained in LAPTg and MRS agar from the assays performed by duplicate are shown. Note: commercial discs do not have the speciﬁcation
of the type of cephalosporin employed.
Halo diameter (mm)
SAM NIT CEP AMP PMD NAL NOR CEC SXT
18 20 18 10 21 22 22 26 14 LAPTg
24 34 28 16 24 14 32 36 38 MRS
29–37 18–22 27–31 27–35 NP NP 17–28 29–37 24–32 M¨ uller Hinton∗
∗Media recommended by NCCLS1. NP: data not published.
were of the same diameters to those obtained in M¨ uller Hin-
ton agar, it would suggest that the disc diﬀusion method
could be performed in LAPTg or MRS with NCCLS refer-
ence strain. Sa u r e u sATCC25922 was inoculated in LAPTg
and MRS agar and the diameters of the halos obtained with
antibiotic discs were compared to those of M¨ uller Hinton. It
was observed that Sa u r e u sATCC25922 was able to grow on
LAPTg and MRS agars. However, the diameters of the halos
were diﬀerent to those published by the NCCLS for M¨ uller
Hinton. The diameters obtained in a M¨ uller Hinton, MRS,
and LAPTg agar are shown in Table 2.
MICs
Considering that the six Lactobacillus strains were able to
grow in LAPTg, this medium was selected to study the
MICs. LAPTg agar or broth was employed and the obtained
results are shown in Tables 3 and 4. All the tested lacto-
bacilliwereabletogrowatelevatedconcentrationofmetron-
idazole (> 1000µg/mL). They were also able to grow at
high concentration of streptomycin (50–100µg/mL), kan-
amycin (100–500µg/mL), quinolones (norﬂoxacin, 250–
1000µg/mL, and ciproﬂoxacin, 10–100µg/mL), chloramph-
enicol (250µg/mL), cephalosporins (ceftriaxone, 100µg/mL;
ceftazidime,100µg/mL), and aztreonam (100µg/mL). For
the other antibiotics assayed, the susceptibility depended on
each particular strain. Lj o h n s o n i iCRL1294 and L paracasei
CRL1289didnotgrowatconcentrationsof1µg/mLofnovo-
biocin and vancomycin, but were able to grow at higher con-
centrations of almost all the other antibiotics (> 100µg/mL).
L acidophilus CRL1266 and L salivarius CRL1328 were able
to grow at 10 and 1000µg/mL of vancomycin, respectively.
DISCUSSION
In this paper, the antimicrobial susceptibility of six probi-
otic vaginal Lactobacillus strains was studied. The knowledge
of the antimicrobial susceptibility or resistance is of inter-
est to predict the behavior of an exogenously applied pro-
biotic formula in patients subject to any type of chemother-
apy, as well as to consider the concomitant use of the pro-
biotic and antibiotics for the restoration of the normal uro-
genital ﬂora. On the other side, antimicrobial susceptibility
of exogenously applied microorganisms needs to be known
for treating eventual collateral eﬀects [19–22]. In this regard,
the performance of antimicrobial susceptibility testing may
be considered as both a necessary selection criterion for pro-
biotic cultures and an eﬀective guide for speciﬁc antimicro-
bial therapy [23].
Up to date, a standardized method to study the antimi-
crobial susceptibility of microorganisms belonging to the
genusLactobacillushasnotbeenpublished,probablybecause4 Infectious Diseases in Obstetrics and Gynecology
Table 3:AntibioticMICs(µg/mL)inLAPTgbrothforvaginal Lactobacillusstrains.STR:streptomycin,KAN:kanamycin,NOR:norﬂoxacin,
NOV: novobiocin, CHL: chloranphenicol, VAN: vancomycin y MTZ: metronidazole. The assays were performed by triplicate.
MIC (µg/mL)
Lactobacillus strain STR KAN NOR NOV CHL VAN MTZ
L acidophilus CRL 1266 50 100 > 1000 10 250 10 > 1000
Lg a s s e r iCRL 1259 50 500 > 1000 10 250 < 1 > 1000
L acidophilus CRL 1251 50 500 500 10 250 < 1 > 1000
L paracasei CRL 1289 50 250 1000 < 1 250 < 1 > 1000
L johnsonii CRL 1294 50 250 750 < 1 250 < 1 > 1000
L salivarius CRL 1328 100 250 250 < 1 250 > 1000 > 1000
Table 4: Antibiotic MIC (µg/mL) in LAPTg agar for vaginal Lactobacillus strains. CRO: ceftriaxone, CTX: cefotaxime, CAZ: ceftazidime,
CIP: ciproﬂoxacin, IPM: imipenem, CLR: clarithromycin, TET: tetracycline, OXA: oxacillin, NIT: nitrofurantoin, ERY: erythromycin, CLI:
clindamycin, AMP: ampicillin, ATM: aztreonam, RIF: rifampin. The assays were performed by triplicate.
MIC (µg/mL)
Lactobacillus strain CRO CTX CAZ CIP IPM CLR TET
L acidophilus CRL 1266 100 100 100 > 100 1 1 100
Lg a s s e r iCRL 1259 > 100 > 100 > 100 > 100 > 100 > 100 > 100
L acidophilus CRL 1251 100 100 100 100 10 10 10
L paracasei CRL 1289 > 100 > 100 > 100 > 100 > 100 > 100 > 100
L johnsonii CRL 1294 > 100 > 100 > 100 > 100 > 100 100 100
L salivarius CRL 1328 100 1 100 10 10 1 1
MIC (µg/mL)
Lactobacillus strain OXA NIT ERY CLI AMP ATM RIF
L acidophilus CRL 1266 > 100 1 100 10 1 100 > 100
Lg a s s e r iCRL 1259 1 1 1 1 > 100 100 0.1
L acidophilus CRL 1251 10 10 1 0.11 > 100 0.1
L paracasei CRL 1289 100 > 100 100 > 100 > 100 100 > 100
L johnsonii CRL 1294 > 100 > 100 > 100 > 100 10 > 100 > 100
L salivarius CRL 1328 10 10 10 0.11 > 100 0.1
they have been considered as “GRAS” for the FDA (Food
and Drug Administration, USA) [24]. The available standard
techniques and the guidelines for the disc diﬀusion method
have been provided by the NCCLS only for selected aero-
bic and anaerobic bacteria or yeasts related with laboratory
clinical diagnostic. However, many researchers have devel-
oped modiﬁcations of the semiquantitative disc assay for lac-
tobacilli [19, 25–28]. Diﬀerent base media and type strains
have been employed but reference data are still not avail-
able. The E-test (AB Biodisk) has also been used and rec-
ommended as an easy diﬀusion test but modiﬁcations of
the original protocol had to be introduced for lactobacilli
[23, 29].
In the present paper, the conventional methodology de-
scribed by Bauer et al [18] was ﬁrst applied. M¨ uller Hinton
base medium was employed to test the eﬀect of the antibi-
otics routinely used for the treatment of urinary tract infec-
tions (UTIs) on Lactobacillus strains. As previouslydescribed
by other researchers [30], the growth of lactobacilli in M¨ uller
Hinton was poor and irregular, and it was not possible to
measure the diameter of the inhibition halos. When LAPTg
was employed instead of M¨ uller Hinton, the growth was op-
timum while in MRS it was appropriate only for some Lac-
tobacillus strains but not for all of them. The last observation
is coherent with the composition of these two media. LAPTg
has a wider variety of nutrients and allows the growth of lac-
tobacilli under aerobic or microaerophilic conditions, while
M R Sa sw e l la sL B S[ 31] seems to be more appropriate for
microaerophilic or anaerobic growth (data not shown).
According to our results, the growth of vaginal lacto-
bacilli in LAPTg and MRS agars was homogeneous and the
inhibition halos were clearly deﬁned (except for Lg a s s e r i
CRL1259 and Lj o h n s o n i iCRL1294 which were not able to
grow in MRS under microaerophilic incubation). Charteris
et al [23, 32] have also used MRS for the disc diﬀusion and
the E-test under anaerobic incubation conditions in both
cases. Based on size of the halos, the mentioned authors have
classiﬁedthemicroorganismsintosusceptible,moderatesus-
ceptible, and resistant. However, the reasons by which they
consider the published ranges for the susceptibility category
are not explained. Considering that the size of the halos de-
pends on the diﬀusion media [33], reference data obtained
in the same media are supposed to be employed for cat-
egorization purposes. Other examples of the use of diﬀer-
ent base media are the publications of Bayer et al [25] that
have used M¨ uller Hinton supplemented with yeast extract
and L-cysteine (0.2% and 0.05%, resp), Felten et al [26]w h o
have employed M¨ uller Hinton with 5% of sheep blood, andVirginia Oca˜ na et al 5
Klein et al [19] who have used the same base media with
h o r s eb l o o d( 3 % ) .M o r er e c e n t l y ,K l a r ee ta l[ 28] proposed
a mixed formulation of Iso-Sensitest broth and MRS with or
without supplementation with L-cysteine and Delgado et al
[27] the use of MRS.
In order to know if LAPTg or MRS could substitute
M¨ uller Hinton as a standard medium, the size of the ha-
los obtained with a closely phylogenetic-related type mi-
croorganism, Sa u r e u sATCC29213 was determined. Diﬀer-
ent publications have cited the use of related type strains for
this type of studies. Klein et al [19] have reported the use of
Enterococcus and Felten et al [26] the use of Staphylococcus
strains. In this study it was observed that the diameters of the
inhibition halos for Sa u r e u sATCC 29213 in LAPTg or MRS
were diﬀerent to those obtained in M¨ uller Hinton. These ob-
servations conﬁrm that the characteristic of “susceptible” or
“resistant”deﬁnedbyNCCLSforassaysperformedwithtype
strains in M¨ uller Hinton agar cannot be considered when
other media are being employed.
The MICs values obtained were dependant on the lac-
tobacilli under consideration as it has also been reported
by Danielsen and Wind [30]. Most of the strains have been
found to be resistant to high concentrations of chloram-
phenicol,aztreonam,norﬂoxacin,ciproﬂoxacin,ceftazidime,
ceftriaxone, and metronidazole. Susceptibility to other an-
tibiotics (rifampicin, erytromicin, novobiocin, vancomycin,
ampicillin,tetracycline,clarithromycin,imipenem,andcefo-
taxime) depended on each particular Lactobacillus strain. On
the other hand, no correlation had been obtained with the
disc diﬀusion method and the MICs results.
Resistance or susceptibility to vancomycin has deserved a
special consideration in terms of classiﬁcation of lactic acid
bacteria, mainly for lactobacilli associated with human in-
fections or isolated from food [26, 34–36]. Hamilton and
Shah [37] have used the susceptibility to vancomycin as an
aid to identify Lactobacillus species. Simpson [35]a n dF e l -
ten et al [26] have associated sensitivity to vancomycin with
the Lactobacillus acidophilus group or those originally called
“Thermobacteria” while Simpson [35] has observed resis-
tance to vancomycin in lactic acid bacteria belonging to the
“Betabacteria” group. However, Klein et al [19]a n dG r i ﬃths
et al [20]h a v er e p o r t e dr e s i s t a n c et ov a n c o m y c i ni nd i ﬀerent
L acidophilus strains isolated from clinical samples. Accord-
ing to the results obtained in this work, 4 of 6 lactobacilli
were able to grow at concentrations lower than 1µ g/mL of
vancomycin. L crispatus and L salivarius, both homofermen-
tatives (Thermobacteria), were able to grow at vancomycin
concentrations higher than 10 and 1000µg, respectively.
Metronidazole and clindamycin are the most commonly
usedantibioticsforthetreatmentofbacterialvaginosis.Can-
didate probiotic Lactobacillus strains were able to grow at
high concentrations of metronidazole and clindamycin, ex-
cept for L acidophilus CRL1251 and L salivarius CRL1328
that did not grow at concentrations as low as 0.1µg/mL of
the last antibiotic. These results suggest that selected strains
could be used for a restoration therapy together with the
antimicrobial bacterial vaginosis treatment. Simoes et al [9]
have also studied the eﬀect of metronidazole on the growth
of vaginal lactobacilli. These authors have observed partial
and complete inhibition at concentration above 1000µg/mL
while they have reported a stimulating eﬀect at concentra-
tions between 128µg/mL and 256µg/mL. Carlstedt-Duke et
al [38]h a v eo b s e r v e dal o we ﬀect of clindamycin on lacto-
bacilli when employing this antibiotic simultaneously with
the lactic acid bacteria to restore the normal ﬂora of the gut
of rats.
Antimicrobial resistance of candidate probiotic lacto-
bacilli was found to be not associated with extra chromo-
somal elements, as plasmids were not found in the strains,
by applying the technique of Maniatis et al [39] (data not
shown). This observation would indicate a low probability
of antibiotic resistance transmission to pathogenic microor-
g a n i s m s .H o w e v e r ,o t h e rd i ﬀerent methods should be tested
to conﬁrm the absence of plasmids, mainly considering that
L salivarius CRL1328 is an aggregating strain able to produce
bacteriocins, both characteristics frequently associated with
extra chromosomal DNA [40, 41].
More studies must be undertaken to deﬁne the adequate
and standardized method to study the antimicrobial suscep-
tibilityoftheLactobacillusgenus.TheuseofLAPTgandMRS
as base media for the disc diﬀusion method deserves further
studies. However, determination of the MICs is, up to date,
the only reliable test to predict the susceptibility or the resis-
tance to antibiotics of Lactobacillus strains.
ACKNOWLEDGMENTS
This paper was supported by grants from Consejo Na-
cional de Investigaciones Cient´ ıﬁcas y T´ ecnicas de Argentina
(CONICET). The Lactobacillus strains employed in this
study were licensed to ANIDRAL (Italy).
REFERENCES
[ 1 ]H a m m e sW ,W e i s sN ,H o l z a p f e lW .T h eg e n e r aLactobacillus
and Carnobacterium.I n :B a l o w sA ,T r ¨ uper H, Dworkin M,
Harder W, Schleifer KH, eds. The Prokaryotes. A Handbook on
the Biology of Bacteria: Ecophysiology, Isolation, Applications.
Vol II. 2nd ed. New York, NY: Springer; 1995:1536–1594.
[2] Fuller R. Probiotics: their development and use. In: Fuller R,
Heidt PJ, Rusch V, Van der Waaij D, eds. Probiotics: Prospects
of Use in Opportunistic Infections. Herborn Dill, Germany: In-
stitute for Microbiology and Biochemistry; 1992:1–7.
[3] Hudault S, Li´ evin V, Bernet-Camard M-F, Servin AL. Antago-
nistic activity exerted in vitro and in vivo by lactobacillus casei
(strainGG) against Salmonella typhimuriumC5infection. Ap-
plied and Environmental Microbiology. 1997;63(2):513–518.
[4] Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lacto-
bacilli in the control and maintenance of the vaginal bacterial
microﬂora.ReviewsofInfectiousDiseases.1990;12(5):856–872.
[5] McGroarty JA. Probiotic use of lactobacilli in the human fe-
male urogenital tract. FEMS Immunology and Medical Micro-
biology. 1993;6(4):251–264.
[6] Boris S, Barb´ es C. Role played by lactobacilli in controlling
the population of vaginal pathogens. Microbes and Infection.
2000;2(5):543–546.
[7] Reid G. The scientiﬁc basis for probiotic strains of Lacto-
bacillus. Applied and Environmental Microbiology. 1999;65(9):
3763–3766.6 Infectious Diseases in Obstetrics and Gynecology
[8] Reid G. Probiotic agents to protect the urogenital tract against
infection. American Journal of Clinical Nutrition. 2001;73(2
suppl):437S–443S.
[9] Simoes JA, Aroutcheva AA, Shott S, Faro S. Eﬀe c to fm e t r o n -
idazole on the growth of vaginal lactobacilli in vitro. Infectious
Diseases in Obstetrics and Gynecology. 2001;9(1):41–45.
[10] Oca˜ naV,BruE,deRuizHolgadoAAP,Nader-Mac´ ıasME.Sur-
face characteristics of lactobacilli isolated from human vagina.
Journal of General and Applied Microbiology. 1999;45(5):203–
212.
[11] Oca˜ na V, Nader-Mac´ ıas ME. Vaginal lactobacilli: self- and
co-aggregating ability. British Journal of Biomedical Science.
2002;59(4):183–190.
[12] Oca˜ na V, Nader-Mac´ ıas ME. Adhesion of Lactobacillus vagi-
nal strains with probiotic properties to vaginal epithelial cells.
Biocell. 2001;25(3):265–273.
[13] Oca˜ na V, de Ruiz Holgado AAP, Nader-Mac´ ıas ME. Selection
of vaginal H2O2-generating Lactobacillus species for probiotic
use. Current Microbiology. 1999;38(5):279–284.
[14] Oca˜ na V, de Ruiz Holgado AAP, Nader-Mac´ ıas ME. Growth
inhibition of Staphylococcus aureus by H2O2-producing Lac-
tobacillus paracasei subsp. paracasei isolated from the hu-
man vagina. FEMS Immunology and Medical Microbiology.
1999;23(2):87–92.
[15] Oca˜ na V, de Ruiz Holgado AAP, Nader-Mac´ ıas ME. Charac-
terization of a bacteriocin-like substance produced by a vagi-
nal Lactobacillus salivarius strain. Applied and Environmental
Microbiology. 1999;65(12):5631–5635.
[16] Raibaud P, Galpin JV, Duclezeau R, Mocquot G, Oliver G. Le
Genre Lactobacillus dans le tube digestif du rat. II. Caracters
de souches heterofermentaires isolates de rats. “holo” et “gno-
toxeniques”.AnnMicrobiologie.AnnalesdeMicrobiologie(An-
nales de L’Institute Pasteur). 1963;124:2223–2235.
[17] De Man JC, Rogosa M, Sharpe ME. A medium for the culti-
vation of lactobacilli. Journal of Applied Bacteriology. 1960;23:
130–135.
[18] Bauer AW, Kirby MM, Sherris JC, Tuurck M. Antibiotic sus-
ceptibility testing by a standarized single disk method. Ameri-
can Journal of Clinical Pathology. 1966;45:493–496.
[19] Klein G, Zill E, Schindler R, Louwers J. Peritonitis associ-
ated with vancomycin-resistant Lactobacillus rhamnosus in a
continuous ambulatory peritoneal dialysis patient: organism
identiﬁcation, antibiotic therapy, and case report. Journal of
Clinical Microbiology. 1998;36(6):1781–1783.
[20] Griﬃths JK, Daly JS, Dodge RA. Two cases of endocarditis
due to Lactobacillus species: antimicrobial susceptibility, re-
view, and discussion of therapy. Clinical Infectious Diseases.
1992;15(2):250–255.
[21] Chomarat M, Espinouse D. Lactobacillus rhamnosus sep-
ticemia in patients with prolonged aplasia receiving ceftazid-
ime-vancomycin. European Journal of Clinical Microbiology
and Infectious Diseases. 1991;10(1):44–48.
[22] Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacil-
lus bacteremia, species identiﬁcation, and antimicrobial sus-
ceptibility of 85 blood isolates. Clinical Infectious Diseases.
2006;42(5):e35–e44.
[23] Charteris WP, Kelly PM, Morelli L, Collins JK. Gradient dif-
fusion antibiotic susceptibility testing of potentially probi-
otic lactobacilli. Journal of Food Protection. 2001;64(12):2007–
2014.
[24] Svenson U. Industrial perspectives. In: Tannock G, ed. Probi-
otics. Chapter 5. Norfolk, England: Horizon Scientiﬁc Press;
1999:57–64.
[25] Bayer AS, Chow AW, Morrison JO, Guze LB. Bactericidal syn-
ergy between penicillin or ampicillin and aminoglycosides
against antibiotic-tolerant lactobacilli. Antimicrobial Agents
and Chemotherapy. 1980;17(3):359–363.
[26] Felten A, Barreau C, Bizet C, Lagrange PH, Philippon A. Lac-
tobacillus species identiﬁcation, H2O2 production, and an-
tibiotic resistance and correlation with human clinical status.
Journal of Clinical Microbiology. 1999;37(3):729–733.
[27] DelgadoS,Fl´ orezAB,MayoB.AntibioticsusceptibilityofLac-
tobacillus and Biﬁdobacterium species from the human gas-
trointestinal tract. Current Microbiology. 2005;50(4):202–207.
[28] Klare I, Konstabel C, M¨ uller-Bertling S, et al. Evaluation of
new broth media for microdilution antibiotic susceptibility
testing of lactobacilli, pediococci, lactococci, and biﬁdobac-
teria. Applied and Environmental Microbiology. 2005;71(12):
8982–8986.
[29] Danielsen M, Andersen HS, Wind A. Use of folic acid casei
medium reveals trimethoprim susceptibility of Lactobacillus
species. Letters in Applied Microbiology. 2004;38(3):206–210.
[30] Danielsen M, Wind A. Susceptibility of Lactobacillus spp. to
antimicrobial agents. International Journal of Food Microbiol-
ogy. 2003;82(1):1–11.
[31] Rogosa M, Sharpe E. Species diﬀerentiation of human vaginal
lactobacilli. Journal of General Microbiology. 1963;23:197–201.
[32] Charteris WP, Kelly PM, Morelli L, Collins JK. Antibiotic sus-
ceptibility of potentially probiotic Lactobacillus species. Jour-
nal of Food Protection. 1998;61(12):1636–1643.
[33] HuysG,D’HaeneK,SwingsJ.Inﬂuenceoftheculturemedium
on antibiotic susceptibility testing of food-associated lactic
acid bacteria with the agar overlay disc diﬀusion method. Let-
ters in Applied Microbiology. 2002;34(6):402–406.
[34] Kneifel W, Toros A, Viernstein H. Diﬀerential enumeration of
silageinoculantsbasedonutilizationofenzymaticactivityand
antibiotic sensitivity of bacteria. Journal of Applied Bacteriol-
ogy. 1994;77(1):42–48.
[35] Simpson WJ, Hammond JRM, Miller RB. Avoparcin and van-
comycin: useful antibiotics for the isolation of brewery lactic
acid bacteria. Journal of Applied Bacteriology. 1988;64(4):299–
309.
[36] Holliman RE, Bone GP. Vancomycin resistance of clinical iso-
lates of lactobacilli. Journal of Infection. 1988;16(3):279–283.
[37] Hamilton-MillerJMT,ShahS.Vancomycinsusceptibilityasan
aid to the identiﬁcation of lactobacilli. Letters in Applied Mi-
crobiology. 1998;26(2):153–154.
[38] Carlstedt-Duke B, Alm L, Hoverstad T, et al. Inﬂuence of clin-
damycin, administered together with or without lactobacilli,
upon intestinal ecology in rats. FEMS Microbiology Ecology.
1987;45(5):251–259.
[ 3 9 ]M a n i a t i sT ,F r i s cE F ,S a m b r o o kJ J .Molecular Cloning Labora-
tory Manual. New York, NY: Cold Spring Harbor Laboratory,
Cold Spring Press; 1982.
[40] RenieroR,CocconcelliP,BottazziV,MorelliL.Highfrequency
of conjugation in Lactobacillus mediated by an aggregation-
promoting factor. Journal of General Microbiology. 1992;138
(4):763–768.
[41] Wang T-T, Lee BH. Plasmids in Lactobacillus. Critical Reviews
in Biotechnology. 1997;17(3):227–272.